FDA approves new Alzheimer's drug, Aduhelm, the first in nearly two decades
The FDA's landmark authorization of Biogen's Aduhelm requires the drug company to conduct a post-approval study to monitor its effectiveness.
Full Article
FDA approves new Alzheimer's drug, Aduhelm, the first in nearly two decades
Upworthy
0 shares
1 views
You might like
Related news coverage
What universal healthcare should look like
Mashable
What universal healthcare should look like
The struggle to cover every American may continue for decades — and we need..
-
Lilly to seek FDA approval for potential Alzheimer's drug
SeattlePI.com
-
The FDA approved a controversial, $56,000-a-year Alzheimer's drug despite opposition inside the agency, internal memos show
Business Insider
-
First patient set to receive controversial Biogen Alzheimer' s drug
MENAFN.com
-
NA Proactive news snapshot: Karora Resources, American Manganese, Idaho Champion Gold Mines Canada, MedX Health, Lingo Media UPDATE ...
Proactive Investors
Advertisement
More coverage
Medicare copays for new Alzheimer's drug could reach $11,500
SeattlePI.com
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are..
-
US FDA okays first new Alzheimer's drug in nearly 2 decades
newKerala.com
-
EXPLAINER: How will insurers cover a new Alzheimer's drug?
SeattlePI.com
-
US approves first new Alzheimer's drug in almost two decades
Digital Journal
-
F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works
Upworthy